Papers on
Nap2
Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome.Vlachoyiannopoulos et al., Athens, Greece. In J Autoimmun, Dec 2015
Increased plasma levels of CXCL4 may favor this process; therefore we measured plasma levels of CXCL4, a CXCL4 variant (CXCL4L1) and as controls, platelet-derived chemokines CXCL7 (NAP-2) and CCL5 (RANTES), in APS, and disease controls such as patients with systemic lupus erythematosus (SLE) coronary artery disease (CAD) and healthy donors (HDs).
Biallelic expression of Tssc4, Nap1l4, Phlda2 and Osbpl5 in adult cattle.Li et al., Baoding, China. In J Genet, Sep 2015
To increase our understanding of imprinted genes in bovine Cdkn1c/Kcnq1ot1 imprinting cluster, we assessed the imprinting status of four cattle genes (Tssc4,Nap1l4, Phlda2 and Osbpl5) in seven types of tissues: heart, liver, spleen, lung, kidney, skeletal muscle and subcutaneous fat using polymorphism-based sequencing approach.
Platelet chemokines in vascular disease.Ley et al., Los Angeles, United States. In Arterioscler Thromb Vasc Biol, 2008
The megakaryocyte CXCL7 gene product is proteolytically cleaved into the strong neutrophil chemoattractant, NAP-2, which has also been implicated in repair cell homing to vascular lesions.
Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation.Oyen et al., Nijmegen, Netherlands. In Q J Nucl Med, 2003
The characteristics of a series of cytokines (IL-1, IL-2), chemokines (IL-8, PF-4, MCP-1, NAP-2), complement factors (C5a, C5adR), chemotactic peptides (fMLF) and other chemotactic factors (LTB4) are described.